Lupin in focus after getting OAI letter from USFDA for MP plant – Business Standard

Mang. Const.

Lupin in focus after getting OAI letter from USFDA for MP plant  Business Standard

Lupin has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at the company’s Mandideep (Unit 1) facility …

Source: Mang. Const.